Skip to main content

Day: June 4, 2025

Request to hold an extraordinary general meeting

Today, on 4 June 2025, Kaldvik AS (the “Company”) received a request from shareholders representing approximately 30% of the shares, to hold an extraordinary general meeting to consider a proposal to open an investigation relating to the agreement entered into between the Company, Heimstø AS and Osval ehf. to acquire 100% of the shares in Mossi ehf., Djupskel ehf., and 33.3% of the shares in Bulandstindur ehf., which was completed on 25 March 2025 and which the shareholders received additional information about in the shareholder meeting held on 24 March 2025. The transaction is further described in separate stock exchange notices from 20 December 2024, 28 February 2025 and 25 March 2025. The proposal requests that further information is provided inter alia about the valuations and the due diligence reports developed in connection...

Continue reading

Frédéric Robert appointed EUROAPI’s Chief Commercial Officer overseeing API Solutions and CDMO activities

  Press Release   Paris – June 4, 2025 – EUROAPI, a European leader in the production of active pharmaceutical ingredients (API) and contract development and manufacturing organization (CDMO), is pleased to announce the appointment of Frédéric Robert to the newly created position of Chief Commercial Officer overseeing API Solutions and CDMO activities. He will join the company’s Executive Committee. This appointment is part of EUROAPI’s ongoing FOCUS-27 transformation plan and reinforces its position as a European leader in the API and CDMO sectors. In his new role, Frédéric Robert will be responsible for creating commercial and organizational synergies between the API Solutions and CDMO operations, delivering our FOCUS-27 sales plan and redefining a global sales strategy for the company. He will also be responsible for expanding...

Continue reading

74Software joins Euronext Tech Leaders, the initiative for high-growth and leading Tech companies

Press Release 74Software joins Euronext Tech Leaders, the initiative for high-growth and leading Tech companies Paris, June 4, 2025 – 74Software is delighted to announce its inclusion in the Euronext Tech Leaders segment, an initiative dedicated to supporting high-growth and leading tech companies. This significant recognition validates the continuous commitment of the company to excellence in entreprise software development and its contribution to digital innovation for nearly 25 years. Launched in June 2022, the Euronext Tech Leaders initiative is backed by a strong network of partners and aims to highlight high-growth and leading tech companies listed on Euronext markets. It features a segment of 110 European companies, an index tracking their performance, and a dedicated programme of services and visibility opportunities designed to...

Continue reading

FG Communities Completes Acquisition in Franklin, North Carolina

Second acquisition in Franklin further solidifies presence in desirable Western North Carolina region MOORESVILLE, N.C., June 04, 2025 (GLOBE NEWSWIRE) — FG Communities, whose mission is to preserve and improve affordable housing by acquiring and operating manufactured housing communities, is excited to announce its most recent acquisition in Franklin, North Carolina. Franklin is located within the Nantahala National Forest, the largest national forest in North Carolina and part of the Blue Ridge Mountains. Residents of the community can spend their time hiking or sightseeing along the Blue Ridge Parkway, or visiting art museums and shopping in Asheville, North Carolina. In addition, the park is located just minutes from downtown Franklin. Franklin, like many popular areas in the mountains of Western North Carolina, has seen a...

Continue reading

Ultrack Systems Inc. (OTC: MJLB) Secures 60% Stake in Better Pets, Charging Into the $325 Billion Pet Wellness Industry with Momentum and Market Vision

TORONTO, June 04, 2025 (GLOBE NEWSWIRE) — Ultrack Systems Inc. (OTC: MJLB), a fast-growing leader in smart logistics technologies, is thrilled to announce the acquisition of a 60% controlling interest in Better Pets, a rising star in the science-driven pet wellness industry. This strategic move catapults MJLB into the booming $325 billion global pet care market—one of the fastest-growing consumer sectors in the world. The transaction, comprised of a mix of cash and equity, also gives Ultrack the right of first refusal to acquire the remaining shares of Better Pets, solidifying its position to take full ownership as the brand scales rapidly. Better Pets: A Brand With Bite Better Pets is not your average pet product company—it’s a forward-thinking health-first brand. Known for its organic, clean-label products like Pet Balm...

Continue reading

Vishay Intertechnology Introduces New High-Reliability Isolation Amplifiers With Industry-Leading CMTI for Precision Applications

Devices Offer Industry-Leading 150 kV/μs CMTI, 400 kHz Bandwidth, and Low Minimum Gain Error of ± 0.3 % MALVERN, Pa., June 04, 2025 (GLOBE NEWSWIRE) — Vishay Intertechnology, Inc. (NYSE: VSH) today announced the release of its latest isolation amplifiers, the VIA0050DD, VIA0250DD, and VIA2000SD. These new devices offer enhanced performance for a wide range of industrial, automotive, and medical applications, where high precision, reliability, and compact size are critical. The VIA series of isolation amplifiers are designed to deliver exceptional thermal stability and precise measurement capabilities. With a typical common-mode transient immunity (CMTI) of 150 kV/μs, these amplifiers provide robust performance even in harsh environments, such as heavy-duty motor applications. The low typical gain error of ± 0.05 % and minimal gain...

Continue reading

DirectMeds Acquires Autumn DNA, Expanding into Precision-Based Personalized Wellness

First-of-its-kind integration introduces DNA-based supplement planning to telehealth—positioning DirectMeds as the leader in data-driven, outcome-focused virtual care SALT LAKE CITY, June 04, 2025 (GLOBE NEWSWIRE) — DirectMeds, a leader in telehealth-driven weight loss treatments, announced the acquisition of Autumn DNA, a personalized supplement company powered by genetic and lifestyle data. The strategic acquisition marks a significant expansion in DirectMeds’ mission to deliver holistic, precision-based wellness solutions to its customer base. Best known for its affordable, medically supervised GLP-1 programs—including Semaglutide and Tirzepatide—DirectMeds will now offer customers the ability to address nutritional gaps, metabolic function, and long-term health through DNA-informed supplementation. Autumn DNA’s proprietary...

Continue reading

Ryman Hospitality Properties, Inc. Announces Closing of $625 Million of 6.500% Senior Notes Due 2033

NASHVILLE, Tenn., June 04, 2025 (GLOBE NEWSWIRE) — Ryman Hospitality Properties, Inc. (NYSE: RHP) (the “Company”) announced today that its subsidiaries, RHP Hotel Properties, LP (the “Operating Partnership”) and RHP Finance Corporation (together with the Operating Partnership, the “Issuers”), completed the previously announced private placement of $625 million aggregate principal amount of 6.500% senior notes due 2033 (the “Notes”). The Notes are senior unsecured obligations of the Issuers and are guaranteed by the Company and its subsidiaries that guarantee the Operating Partnership’s existing credit facility, 4.750% senior unsecured notes due 2027, 7.250% senior unsecured notes due 2028, 4.500% senior unsecured notes due 2029 and 6.500% senior unsecured notes due 2032. The aggregate net proceeds from the sale of the Notes are...

Continue reading

ALK participates at Jefferies Global Healthcare Conference 2025 in New York

ALK (ALKB:DC / OMX: ALK B) today announced that the company is participating at the Jefferies Global Healthcare Conference 2025 in New York City taking place from 3 – 5 June 2025. Claus Steensen Sølje, Executive Vice President and CFO, this morning (EDT) participated in a fireside chat at the conference. A webcast replay of the fireside chat is available on ALK’s investor site: Investors | ALK or through this link. ALK-Abelló A/S For further information please contact: Investor Relations: Per Plotnikof, tel. +45 4574 7527, mobile +45 2261 2525 Media: Maiken Riise Andersen, tel. +45 5054 1434 About ALKALK is a global specialty pharmaceutical company focused on allergy and allergic asthma. ALK manufactures and markets allergy immunotherapy (‘AIT’) treatments and other products and services for people with allergy and allergy...

Continue reading

GDS to Hold Annual General Meeting on June 26, 2025

SHANGHAI, China, June 04, 2025 (GLOBE NEWSWIRE) — GDS Holdings Limited (“GDS Holdings”, “GDS” or the “Company”) (NASDAQ: GDS; HKEX: 9698), a leading developer and operator of high-performance data centers in China, today announced that it will hold its 2025 Annual General Meeting of Shareholders (the “AGM”) at Beijing Meeting Room, F5, Building C, Sunland International, No. 999 Zhouhai Road, Pudong, Shanghai, P.R.C. at 4:00 p.m. (China Standard Time) on June 26, 2025 (which is 4:00 a.m. (Eastern Daylight Time) on June 26, 2025). Holders of the Company’s ordinary shares and Series A convertible preferred shares listed in the register of members of the Company at the close of business on June 4, 2025 (China Standard Time) are entitled to receive notice of, and vote at, the AGM or at any adjournment that may take place. Beneficial...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.